MEDPLUS NSE · Consumer Services · Retailing
Medplus Health Services Limited
₹654.90 NSE close, 25 Sep 2026
Data as of 10 sources, each card shows its own date MF: Aug 2026 portfolios (monthly), 20 AMCs Shares outstanding and close: NSE, 25 Sep 2026 Delivery: NSE bhavcopy, 25 Sep 2026 · 30 days collected Deals: NSE deal files, 25 Sep 2026 · collected since 25 Sep 2026 SLBM: NSE, 25 Sep 2026 · 30 days collected MTF: NSE, 24 Sep 2026 · 29 days collected Flags: NSE, 25 Sep 2026 FPI: Shareholding pattern as of 30 Jun 2026, filed 18 Jul 2026 Pledge: Shareholding pattern as of 30 Jun 2026 Insider: Disclosures filed 29 Jun 2026 to 26 Sep 2026 (collected since 3 May 2026)
MF houses FPIs Insider and promoter Bulk and block deals Promoter pledge SLBM borrowing MTF book Delivery Red flags
MF holding, % of equity
22.52% ▲ +1.61 pp
Aug 2026 · change vs Jul 2026 over 20 AMCs with both months, all schemes
FPI holding, % of equity
14.38%
as of 30 Jun 2026
Fund houses holding
5 no change
0 entered, 0 exited · Aug 2026 · index funds hidden
Promoter pledge
60.74%
as of 30 Jun 2026
What changed
5 tracked fund houses held MEDPLUS in Aug 2026. None entered or exited.
All tracked schemes together held 2.71 cr shares, 22.52% of equity, worth ₹1,819 cr at the end of Aug 2026.
Index and arbitrage funds held 0.16% of equity; they are left out of the fund-house counts.
MF houses Aug 2026
5 no change m/m
Top buyer ICICI Prudential Mutual Fund, +1.54% of equity. Index and arbitrage funds hidden.
Named FPIs at 1% or more as of 30 Jun 2026
14.38%
FPI category I + II, % of total shares · 2 named at 1% or more
FPIs named at 1% or more on 30 Jun 2026: FIDELITY FUNDS - INDIA FOCUS FUND 1.68%; KUWAIT INVESTMENT AUTHORITY FUND 227 1.55%.
Insider and promoter 29 Jun 2026 to 26 Sep 2026
1 ▲ net +3,725 sh
disclosed transactions · equity bought 3,725 sh, sold 0 sh
Latest: Alka Ajit Rangnekar (Directors Immediate Relative), Buy 3,725 Equity worth ₹24,45,463, 17 Aug 2026, Off Market.
Bulk and block deals 25 Sep 2026
No bulk or block deals in MEDPLUS on 25 Sep 2026.
Promoter pledge as of 30 Jun 2026
60.74%
of promoter holding · 24.41% of total shares
Promoters had pledged 2.93 cr of their 4.83 cr shares on 30 Jun 2026; 2.93 cr encumbered in all (pledge, NDU and other).
SLBM borrowing 25 Sep 2026
NSE listed no SLBS open position for MEDPLUS on any of the 30 days collected, 14 Aug 2026 to 25 Sep 2026. No SLBM trades in MEDPLUS on 25 Sep 2026.
MTF book 24 Sep 2026
2.46 lakh sh ▲ +1,817 vs 23 Sep 2026
percentile 7 of 29 days collected · ₹19.3 cr financed
2.46 lakh shares, 0.21% of equity in the margin trading book at the end of 24 Sep 2026; that day sits at percentile 7 of 29 days collected.
Delivery 25 Sep 2026
73.3% ▲ +15.1 pp vs 20-day average
20-day average 58.2% · percentile 97 of 30 days collected
73.3% of the shares traded on 25 Sep 2026 were delivered, against a 20-day average of 58.2%; that day sits at percentile 97 of 30 days collected.
Red flags 25 Sep 2026
No F&O
MEDPLUS has no F&O contracts in NSE's combined open-interest file, so the F&O ban does not apply. NSE listed MEDPLUS under no ASM or GSM stage on 25 Sep 2026. Pledge invocations are not collected yet.